| Breast Cancer |
1 |
1 |
| Biologic Therapy |
0 |
0.89 |
| Triple Negative Breast Cancer |
0 |
0.99 |
| Head and Neck Cancer |
0 |
0.51 |
| Cancer |
0 |
0.47 |
| Breast |
0 |
0.43 |
| Chemotherapy |
0 |
0.98 |
| Metastasis |
0 |
0.97 |
| Hodgkin Lymphoma |
0 |
0.36 |
| Quality of Life |
0 |
0.35 |
| Antibody Drug Conjugates |
0 |
0.31 |
| Brachial |
0 |
0.31 |
| Receptors |
0 |
0.16 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.14 |
| Brain Metastasis |
0 |
0.14 |
| HIV Infection |
0 |
0.14 |
| Pain Management |
0 |
0.14 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.12 |
| Brain |
0 |
0.08 |
| Europe |
0 |
0.08 |
| Antigens |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Diarrhea |
0 |
0.04 |
| Dyspnea |
0 |
0.04 |
| Endocrine Therapy |
0 |
0.04 |
| Fatigue |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Insomnia |
0 |
0.04 |
| Massachusetts |
0 |
0.04 |
| Pain |
0 |
0.04 |
| Sleep Disorders |
0 |
0.04 |
| Texas |
0 |
0.04 |